Dutros 0.5 Tablet
Marketer
Demorbus India Pvt Ltd
Salt Composition
Dutasteride (0.5mg)
Overview Dutros 0.5 Tablet
Benign prostatic hyperplasia (BPH) is treated with Dutros 0.5mg tablets, which reduce prostate gland size, alleviating urinary discomfort and pain. Administered orally, with or without food, Dutros requires consistent use over several months for optimal results. Complete the prescribed course as directed by your physician; though generally well-tolerated, mild decreased libido may occur. Post-treatment, refrain from blood donation for six months.
Primary Ingredients of Dutros 0.5 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Dutros 0.5 Tablet
Noncancerous prostate gland enlargement
Major Benefits of Dutros 0.5 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dutros 0.5mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dutros 0.5 Tablet:
- Decreased libido
- Ejaculation disorder
- Breast enlargement in male
- Breast tenderness in male
- Impotence
- Decreased sperm count
How to use Dutros 0.5 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dutros 0.5mg tablets can be consumed with or without food; however, consistent timing is recommended.
How Dutros 0.5 Tablet works:
Dutros 0.5mg tablets contain a 5-alpha reductase inhibitor. This medication works by inhibiting the enzyme responsible for converting testosterone into a hormone that stimulates prostate growth. Consequently, prostate size is reduced, alleviating symptoms such as urinary hesitancy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dutros 0.5 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
The use of Dutros 0.5 Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal and human studies indicates substantial risk of harm to the fetus.
Breast feedingUNSAFE
Breastfeeding women should not use Dutros 0.5 Tablet. Evidence indicates potential infant toxicity. This medication is contraindicated in women.
DrivingSAFE
Driving ability is typically unaffected by Dutros 0.5 Tablet.
KidneySAFE IF PRESCRIBED
The use of Dutros 0.5 Tablet in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Dutros 0.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Dutros 0.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Dutros 0.5 Tablet :
Should you forget to take a Dutros 0.5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dutros 0.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Androgen-Based Compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |


